Literature DB >> 29687308

Exposure to Far Infrared Ray Protects Methamphetamine-Induced Behavioral Sensitization in Glutathione Peroxidase-1 Knockout Mice via Attenuating Mitochondrial Burdens and Dopamine D1 Receptor Activation.

Huynh Nhu Mai1, Naveen Sharma1, Eun-Joo Shin1, Bao Trong Nguyen1, Ji Hoon Jeong2, Choon-Gon Jang3, Eun-Hee Cho4, Seung Yeol Nah5, Nam Hun Kim6, Toshitaka Nabeshima7, Hyoung-Chun Kim8.   

Abstract

Evidence indicates that stress conditions might lead to drug dependence. Recently, we have demonstrated that exposure to far infrared ray (FIR) attenuates acute restraint stress via induction of glutathione peroxidase-1 (GPx-1) gene. We investigated whether FIR affects methamphetamine (MA)-induced behavioral sensitization and whether FIR-mediated pharmacological activity requires interaction between dopamine receptor and GPx-1 gene. We observed that MA treatment significantly increased GPx-1 expression in the striatum of wild-type (WT) mice. Interestingly, exposure to FIR potentiated MA-induced increase in GPx-1 expression. This phenomenon was also observed in animals receiving MA with dopamine D1 receptor antagonist SCH23390. However, dopamine D2 receptor antagonist sulpiride did not affect MA-induced GPx-1 expression. FIR exposure or SCH23390, but not sulpiride, significantly attenuated MA-induced behavioral sensitization. Exposure to FIR significantly attenuated MA-induced dopamine D1 receptor expression, c-Fos induction and oxidative burdens. FIR-mediated antioxidant effects were also more pronounced in mitochondrial- than cytosolic-fraction. In addition, FIR significantly attenuated against MA-induced changes in mitochondrial superoxide dismutase and mitochondrial GPx activities, mitochondrial transmembrane potential, intramitochondrial Ca2+ level, mitochondrial complex-I activity, and mitochondrial oxidative burdens. The attenuation by FIR was paralleled that by SCH23390. Effects of FIR or SCH23390 were more sensitive to GPx-1 KO than WT mice, while SCH23390 treatment did not exhibit any additive effects on the protective activity mediated by FIR, indicating that dopamine D1 receptor constitutes a molecular target of FIR. Our result suggests that exposure to FIR ameliorates MA-induced behavioral sensitization via possible interaction between dopamine D1 receptor and GPx-1 gene.

Entities:  

Keywords:  Dopamine D1 receptor; Far infrared ray; Glutathione peroxidase-1 knockout mice; Methamphetamine-induced behavioral sensitization; Mitochondrial burdens; Striatum

Mesh:

Substances:

Year:  2018        PMID: 29687308     DOI: 10.1007/s11064-018-2528-5

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  70 in total

1.  Mood stabilizer lithium inhibits amphetamine-increased 4-hydroxynonenal-protein adducts in rat frontal cortex.

Authors:  Hua Tan; L Trevor Young; Li Shao; Yi Che; William G Honer; Jun-Feng Wang
Journal:  Int J Neuropsychopharmacol       Date:  2011-09-23       Impact factor: 5.176

2.  Far infrared radiation (FIR): its biological effects and medical applications.

Authors:  Fatma Vatansever; Michael R Hamblin
Journal:  Photonics Lasers Med       Date:  2012-11-01

3.  Dopamine D1 receptor-mediated toxicity in human SK-N-MC neuroblastoma cells.

Authors:  Charbel E-H Moussa; York Tomita; Anita Sidhu
Journal:  Neurochem Int       Date:  2005-11-14       Impact factor: 3.921

Review 4.  Current understanding of methamphetamine-associated dopaminergic neurodegeneration and psychotoxic behaviors.

Authors:  Eun-Joo Shin; Duy-Khanh Dang; The-Vinh Tran; Hai-Quyen Tran; Ji Hoon Jeong; Seung-Yeol Nah; Choon-Gon Jang; Kiyofumi Yamada; Toshitaka Nabeshima; Hyoung-Chun Kim
Journal:  Arch Pharm Res       Date:  2017-02-28       Impact factor: 4.946

5.  Dopamine D(1) receptor deletion strongly reduces neurotoxic effects of methamphetamine.

Authors:  S Ares-Santos; N Granado; I Oliva; E O'Shea; E D Martin; M I Colado; R Moratalla
Journal:  Neurobiol Dis       Date:  2011-11-13       Impact factor: 5.996

6.  Ginsenoside Re protects methamphetamine-induced mitochondrial burdens and proapoptosis via genetic inhibition of protein kinase C δ in human neuroblastoma dopaminergic SH-SY5Y cell lines.

Authors:  Yunsung Nam; Myung Bok Wie; Eun-Joo Shin; Thuy-Ty Lan Nguyen; Seung-Yeol Nah; Sung Kwon Ko; Ji Hoon Jeong; Choon-Gon Jang; Hyoung-Chun Kim
Journal:  J Appl Toxicol       Date:  2014-12-18       Impact factor: 3.446

7.  Increased mitochondrial complex I activity in platelets of schizophrenic patients.

Authors:  Dorit Ben-Shachar; Rosa Zuk; Haifa Gazawi; Alon Reshef; Ala Sheinkman; Ehud Klein
Journal:  Int J Neuropsychopharmacol       Date:  1999-12       Impact factor: 5.176

Review 8.  Mitochondria, Ca2+ and neurodegenerative disease.

Authors:  Charles Krieger; Michael R Duchen
Journal:  Eur J Pharmacol       Date:  2002-07-05       Impact factor: 4.432

Review 9.  Oxidative stress, glutamate, and neurodegenerative disorders.

Authors:  J T Coyle; P Puttfarcken
Journal:  Science       Date:  1993-10-29       Impact factor: 47.728

10.  Far infra-red therapy promotes ischemia-induced angiogenesis in diabetic mice and restores high glucose-suppressed endothelial progenitor cell functions.

Authors:  Po-Hsun Huang; Jaw-Wen Chen; Chih-Pei Lin; Ying-Hwa Chen; Chao-Hung Wang; Hsin-Bang Leu; Shing-Jong Lin
Journal:  Cardiovasc Diabetol       Date:  2012-08-15       Impact factor: 9.951

View more
  1 in total

1.  Isoliquiritigenin, a potent human monoamine oxidase inhibitor, modulates dopamine D1, D3, and vasopressin V1A receptors.

Authors:  Ritu Prajapati; Su Hui Seong; Se Eun Park; Pradeep Paudel; Hyun Ah Jung; Jae Sue Choi
Journal:  Sci Rep       Date:  2021-12-07       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.